Navigation Links
Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S.
Date:10/17/2011

tive nasal agents to treat allergic rhinitis for potentially impaired pain management.

Use In Specific Populations

  • Safety and efficacy below 18 years of age have not been established.
  • There are no adequate and well-controlled studies of Lazanda in pregnant women.  Do not use Lazanda during labor and delivery or in women who are nursing.
  • Lazanda should be administered with caution in patients with impaired renal or hepatic function and titrated to clinical effect in patients with severe renal or hepatic disease.

  • Adverse Reactions

  • Most common adverse events during titration (frequency greater than or equal to 5%): nausea, vomiting, and dizziness.
  • Most common adverse events during maintenance (frequency greater than or equal to 5%): vomiting, nausea, pyrexia, and constipation.

  • Please see the accompanying full Prescribing Information including boxed warning. For more information, please visit http://www.lazanda.com/Lazanda_PI.pdf.

    About Archimedes PharmaArchimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments to address unmet needs for people living with serious or life-threatening chronic and debilitating illnesses.  Archimedes Pharma markets a diverse portfolio of speciality products and has operations in the U.S. and throughout Europe.  Archimedes Pharma U.S. Inc. is a subsidiary of Archimedes Pharma Ltd. For more information, please visit: www.ArchimedesPharma.com.

    Lazanda®, PecFent®, and PecSys® are registered trademarks of Archimedes Development Ltd.

    ARCH-2011-007


    '/>"/>

    SOURCE Archimedes Pharma Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
    2. Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
    3. Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
    4. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
    5. Novo Nordisk A/S: PharmaVitae Profile
    6. Auxilium Pharmaceuticals to Announce Third Quarter 2011 Results and Conduct Conference Call on Monday, October 31, 2011
    7. Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES
    8. Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors
    9. Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
    10. CVS/pharmacy Ready to Provide Assistance During Medicare Part D Annual Enrollment Period
    11. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/1/2014)... Aug. 1, 2014 In the latest call ... sexual dysfunction, more than 60 doctors and leading medical ... letter questioning the Food and Drug Administration,s (FDA) decision ... form of male sexual dysfunction compared with ZERO for ... to act for women by approving the first-ever drug ...
    (Date:8/1/2014)... , Ill. and PALO ALTO, Calif. ... Fibrosis Research, Inc. (CFRI) today announced a partnership to ... fibrosis (CF) community through the CFChef Shares program. CFChef ... 2014, as part of AbbVie,s CFChef program – an ... encourage patients to maintain a healthy diet by submitting ...
    (Date:8/1/2014)... Calif. , Aug. 1, 2014  Isis Pharmaceuticals, ... initiation of a pivotal Phase 3 study evaluating ISIS-SMN ... the most common genetic cause of infant mortality. Isis ... within the next few weeks, at which time Isis ... development partner, Biogen Idec. The Phase 3 study, ENDEAR, ...
    Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5
    ... research sponsored by CVS Caremark examined the effects ... on medication adherence when the warnings are not ... that immediately following a high-profile FDA communication questioning ... level of patients who stopped filling their prescription ...
    ... 23 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... EAS 2012When:Friday, June 1st at 12:00 p.m. ET / ... our Web site listed above. If you are unable ... the webcast will be available for a limited time ...
    Cached Medicine Technology:CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 2CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 3
    (Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
    (Date:8/1/2014)... 01, 2014 Hot off the presses after ... category of the World’s Best Awards by Travel + ... celebration of National Relaxation Day (technically August 15). , ... MAJOR experts to help guests celebrate relaxation throughout the month ... for health and wellness to carve out time to relax ...
    (Date:8/1/2014)... Mozes HealthDay Reporter FRIDAY, ... serve as a time-honored destination for a good cut and ... might also be the spot to tackle an often overlooked ... a novel partnership, the U.S. Centers for Disease Control and ... enlisted the help of barbershop staff to both discuss and ...
    (Date:8/1/2014)... August 01, 2014 For years, proponents ... A recent study conducted by the Ohio ... too far behind in terms of their health and ... know what’s best for their baby. So does this ... Dr. Steven Shapiro , chair of Pediatrics at ...
    (Date:8/1/2014)... GlobalDatas new report, "United ... provides key market data on the United ... value, in millions of US dollars, volume ... dollars) within market segments - Electrosurgical RF ... Plasma Coagulation Generators. , To view the ...
    Breaking Medicine News(10 mins):Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3
    ... and Drug Administration (FDA) has approved the NeuRx Diaphragm ... dependent on ventilators for breathing. The light-weight, battery-powered ... naturally, while eliminating the need for a power source ... was developed over the course of 20 years through ...
    ... safety program launched more than two years ago ... significantly improved communication between caregivers and patients and ... the program has found. , Children,s Hospital became ... with the Josie King Foundation to launch a ...
    ... proVision(TM) Now Manages Over 150,000 Identities, ANDOVER, ... the past six months, seven healthcare organizations have ... processes that eliminate the challenges of manual user ... (Nashville, TN) -- Baptist Health System (Birmingham, ...
    ... inspiring stories of Minnesotans who ... struggled to ... personally struggled to go smoke-free are sharing their,stories, from the time ... Their inspiring stories will be showcased in,ClearWay Minnesota,s traveling photo essay ...
    ... born by Caesarean section have a 50 % increased risk ... sections increase the risk even further. This is shown in ... registered at the Medical Birth Registry at the Norwegian Institute ... was to investigate the possible link between being born by ...
    ... CHAPEL HILL Psychosocial influences such as stress, depression ... studies involving people infected with HIV, yet they are ... individuals and the spread of AIDS, according to a ... , Now, a comprehensive update on those influences in ...
    Cached Medicine News:Health News:FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients 2Health News:Study finds Children's Hospital patient safety program improves caregiver/family communications 2Health News:Leading Healthcare Organizations Overwhelmingly Select Sentillion for User Provisioning 2Health News:Leading Healthcare Organizations Overwhelmingly Select Sentillion for User Provisioning 3Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 2Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 3Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 4Health News:Caesarean sections associated with risk of asthma 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 3
    ... Parathyroid hormone (PTH) is synthesized ... secreted in response to decreased extracellular ... enhancing bone resorption and decreasing calcium ... into the circulation, intact PTH is ...
    ... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
    ... steroid, is one of the most potent ... testosterone is secreted primarily by the testes ... peripheral conversion of androstenedione [2]. In adult ... 50% of serum testosterone is derived from ...
    ... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
    Medicine Products: